First Mercantile Trust’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-118
| Closed | -$30K | – | 879 |
|
2020
Q3 | $30K | Sell |
118
-30
| -20% | -$7.63K | ﹤0.01% | 817 |
|
2020
Q2 | $51K | Sell |
148
-4
| -3% | -$1.38K | 0.01% | 776 |
|
2020
Q1 | $41K | Sell |
152
-5
| -3% | -$1.35K | 0.01% | 732 |
|
2019
Q4 | $51K | Sell |
157
-13
| -8% | -$4.22K | 0.01% | 788 |
|
2019
Q3 | $46K | Sell |
170
-79
| -32% | -$21.4K | ﹤0.01% | 826 |
|
2019
Q2 | $132K | Sell |
249
-28
| -10% | -$14.8K | 0.01% | 571 |
|
2019
Q1 | $140K | Sell |
277
-23
| -8% | -$11.6K | 0.03% | 573 |
|
2018
Q4 | $148K | Sell |
300
-93
| -24% | -$45.9K | 0.04% | 528 |
|
2018
Q3 | $359K | Buy |
393
+81
| +26% | +$74K | 0.07% | 332 |
|
2018
Q2 | $229K | Buy |
312
+10
| +3% | +$7.34K | 0.05% | 473 |
|
2018
Q1 | $480K | Sell |
302
-30
| -9% | -$47.7K | 0.1% | 256 |
|
2017
Q4 | $298K | Buy |
+332
| New | +$298K | 0.06% | 408 |
|
2016
Q2 | – | Sell |
-446
| Closed | -$92K | – | 907 |
|
2016
Q1 | $92K | Sell |
446
-88
| -16% | -$18.2K | 0.01% | 760 |
|
2015
Q4 | $135K | Buy |
+534
| New | +$135K | 0.01% | 744 |
|
2013
Q3 | – | Sell |
-777
| Closed | -$135K | – | 1190 |
|
2013
Q2 | $135K | Buy |
+777
| New | +$135K | 0.01% | 833 |
|